【摘要】 目的评价瑞替普酶联合低分子肝素钙治疗急性心肌梗死的疗效。方法将500例急性心肌梗死患者分成对照组(瑞替普酶与普通肝素治疗)与观察组(瑞替普酶与低分子肝素钙治疗),观察临床治疗效果。结果观察组与对照组治疗总有效率比较,差异不具有统计学意义(P>0.05)。观察组并发症发生率低于对照组比较(P<0.05)。观察组胸痛缓解时间与ST段回降>50%时间比对照组短(P<0.05)。结论瑞替普酶联合低分子肝素钙治疗急性心肌梗死,疗效满意。更多还原

【Abstract】 Objective To evaluate the efficacy of reteplase combined with low molecular weight heparin calcium in the treatment of acute myocardial infarction.Methods 500 patients with acute myocardial infarction were divided into control group(reteplase and ordinary heparin treatment) and observation group(reteplase and low molecular weight heparin calcium treatment).Results The total effective rate of the observation group and the control group was not statistically significant(P > 0.05).The incidence of complications in the observation group was lower than that in the control group(P<0.05).The time of chest pain relief and ST segment regression >50% in the observation group was shorter than that in the control group(P<0.05).Conclusion The therapeutic effect of zheparin calcium on acute myocardial infarction is satisfactory.更多还原